Global Biosuperior Supply, Demand and Key Producers, 2023-2029
The global Biosuperior market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
This report studies the global Biosuperior production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosuperior, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosuperior that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosuperior total production and demand, 2018-2029, (K Units)
Global Biosuperior total production value, 2018-2029, (USD Million)
Global Biosuperior production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biosuperior consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Biosuperior domestic production, consumption, key domestic manufacturers and share
Global Biosuperior production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Biosuperior production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biosuperior production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Biosuperior market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen and CSL Behring GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosuperior market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biosuperior Market, By Region:
1. How big is the global Biosuperior market?
2. What is the demand of the global Biosuperior market?
3. What is the year over year growth of the global Biosuperior market?
4. What is the production and production value of the global Biosuperior market?
5. Who are the key producers in the global Biosuperior market?
6. What are the growth factors driving the market demand?
Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
This report studies the global Biosuperior production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosuperior, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosuperior that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosuperior total production and demand, 2018-2029, (K Units)
Global Biosuperior total production value, 2018-2029, (USD Million)
Global Biosuperior production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biosuperior consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Biosuperior domestic production, consumption, key domestic manufacturers and share
Global Biosuperior production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Biosuperior production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biosuperior production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Biosuperior market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen and CSL Behring GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosuperior market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biosuperior Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- G-CSF Biobetters
- Insulin Biobetters
- Erythropoietin Biobetters
- Monoclonal Antibodies Biobetters
- Others
- Cancer
- Diabetes
- Genetic Disease
- Neurological Disorders
- Others
- F.Hoffmann-La Roche AG
- Merck and Co.
- Sanofi
- SERVIER
- Porton Biopharma
- Eli Lily and Company
- Novo Nordisk
- Biogen
- CSL Behring GmbH
- Teva
1. How big is the global Biosuperior market?
2. What is the demand of the global Biosuperior market?
3. What is the year over year growth of the global Biosuperior market?
4. What is the production and production value of the global Biosuperior market?
5. Who are the key producers in the global Biosuperior market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biosuperior Introduction
1.2 World Biosuperior Supply & Forecast
1.2.1 World Biosuperior Production Value (2018 & 2022 & 2029)
1.2.2 World Biosuperior Production (2018-2029)
1.2.3 World Biosuperior Pricing Trends (2018-2029)
1.3 World Biosuperior Production by Region (Based on Production Site)
1.3.1 World Biosuperior Production Value by Region (2018-2029)
1.3.2 World Biosuperior Production by Region (2018-2029)
1.3.3 World Biosuperior Average Price by Region (2018-2029)
1.3.4 North America Biosuperior Production (2018-2029)
1.3.5 Europe Biosuperior Production (2018-2029)
1.3.6 China Biosuperior Production (2018-2029)
1.3.7 Japan Biosuperior Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosuperior Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biosuperior Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biosuperior Demand (2018-2029)
2.2 World Biosuperior Consumption by Region
2.2.1 World Biosuperior Consumption by Region (2018-2023)
2.2.2 World Biosuperior Consumption Forecast by Region (2024-2029)
2.3 United States Biosuperior Consumption (2018-2029)
2.4 China Biosuperior Consumption (2018-2029)
2.5 Europe Biosuperior Consumption (2018-2029)
2.6 Japan Biosuperior Consumption (2018-2029)
2.7 South Korea Biosuperior Consumption (2018-2029)
2.8 ASEAN Biosuperior Consumption (2018-2029)
2.9 India Biosuperior Consumption (2018-2029)
3 WORLD BIOSUPERIOR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biosuperior Production Value by Manufacturer (2018-2023)
3.2 World Biosuperior Production by Manufacturer (2018-2023)
3.3 World Biosuperior Average Price by Manufacturer (2018-2023)
3.4 Biosuperior Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biosuperior Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biosuperior in 2022
3.5.3 Global Concentration Ratios (CR8) for Biosuperior in 2022
3.6 Biosuperior Market: Overall Company Footprint Analysis
3.6.1 Biosuperior Market: Region Footprint
3.6.2 Biosuperior Market: Company Product Type Footprint
3.6.3 Biosuperior Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biosuperior Production Value Comparison
4.1.1 United States VS China: Biosuperior Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biosuperior Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biosuperior Production Comparison
4.2.1 United States VS China: Biosuperior Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biosuperior Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biosuperior Consumption Comparison
4.3.1 United States VS China: Biosuperior Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biosuperior Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biosuperior Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biosuperior Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biosuperior Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biosuperior Production (2018-2023)
4.5 China Based Biosuperior Manufacturers and Market Share
4.5.1 China Based Biosuperior Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biosuperior Production Value (2018-2023)
4.5.3 China Based Manufacturers Biosuperior Production (2018-2023)
4.6 Rest of World Based Biosuperior Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biosuperior Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biosuperior Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biosuperior Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosuperior Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 G-CSF Biobetters
5.2.2 Insulin Biobetters
5.2.3 Erythropoietin Biobetters
5.2.4 Monoclonal Antibodies Biobetters
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Biosuperior Production by Type (2018-2029)
5.3.2 World Biosuperior Production Value by Type (2018-2029)
5.3.3 World Biosuperior Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosuperior Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Diabetes
6.2.3 Genetic Disease
6.2.4 Neurological Disorders
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Biosuperior Production by Application (2018-2029)
6.3.2 World Biosuperior Production Value by Application (2018-2029)
6.3.3 World Biosuperior Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 F.Hoffmann-La Roche AG
7.1.1 F.Hoffmann-La Roche AG Details
7.1.2 F.Hoffmann-La Roche AG Major Business
7.1.3 F.Hoffmann-La Roche AG Biosuperior Product and Services
7.1.4 F.Hoffmann-La Roche AG Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 F.Hoffmann-La Roche AG Recent Developments/Updates
7.1.6 F.Hoffmann-La Roche AG Competitive Strengths & Weaknesses
7.2 Merck and Co.
7.2.1 Merck and Co. Details
7.2.2 Merck and Co. Major Business
7.2.3 Merck and Co. Biosuperior Product and Services
7.2.4 Merck and Co. Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck and Co. Recent Developments/Updates
7.2.6 Merck and Co. Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Biosuperior Product and Services
7.3.4 Sanofi Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 SERVIER
7.4.1 SERVIER Details
7.4.2 SERVIER Major Business
7.4.3 SERVIER Biosuperior Product and Services
7.4.4 SERVIER Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 SERVIER Recent Developments/Updates
7.4.6 SERVIER Competitive Strengths & Weaknesses
7.5 Porton Biopharma
7.5.1 Porton Biopharma Details
7.5.2 Porton Biopharma Major Business
7.5.3 Porton Biopharma Biosuperior Product and Services
7.5.4 Porton Biopharma Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Porton Biopharma Recent Developments/Updates
7.5.6 Porton Biopharma Competitive Strengths & Weaknesses
7.6 Eli Lily and Company
7.6.1 Eli Lily and Company Details
7.6.2 Eli Lily and Company Major Business
7.6.3 Eli Lily and Company Biosuperior Product and Services
7.6.4 Eli Lily and Company Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Eli Lily and Company Recent Developments/Updates
7.6.6 Eli Lily and Company Competitive Strengths & Weaknesses
7.7 Novo Nordisk
7.7.1 Novo Nordisk Details
7.7.2 Novo Nordisk Major Business
7.7.3 Novo Nordisk Biosuperior Product and Services
7.7.4 Novo Nordisk Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk Recent Developments/Updates
7.7.6 Novo Nordisk Competitive Strengths & Weaknesses
7.8 Biogen
7.8.1 Biogen Details
7.8.2 Biogen Major Business
7.8.3 Biogen Biosuperior Product and Services
7.8.4 Biogen Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biogen Recent Developments/Updates
7.8.6 Biogen Competitive Strengths & Weaknesses
7.9 CSL Behring GmbH
7.9.1 CSL Behring GmbH Details
7.9.2 CSL Behring GmbH Major Business
7.9.3 CSL Behring GmbH Biosuperior Product and Services
7.9.4 CSL Behring GmbH Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CSL Behring GmbH Recent Developments/Updates
7.9.6 CSL Behring GmbH Competitive Strengths & Weaknesses
7.10 Teva
7.10.1 Teva Details
7.10.2 Teva Major Business
7.10.3 Teva Biosuperior Product and Services
7.10.4 Teva Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Teva Recent Developments/Updates
7.10.6 Teva Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosuperior Industry Chain
8.2 Biosuperior Upstream Analysis
8.2.1 Biosuperior Core Raw Materials
8.2.2 Main Manufacturers of Biosuperior Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biosuperior Production Mode
8.6 Biosuperior Procurement Model
8.7 Biosuperior Industry Sales Model and Sales Channels
8.7.1 Biosuperior Sales Model
8.7.2 Biosuperior Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biosuperior Introduction
1.2 World Biosuperior Supply & Forecast
1.2.1 World Biosuperior Production Value (2018 & 2022 & 2029)
1.2.2 World Biosuperior Production (2018-2029)
1.2.3 World Biosuperior Pricing Trends (2018-2029)
1.3 World Biosuperior Production by Region (Based on Production Site)
1.3.1 World Biosuperior Production Value by Region (2018-2029)
1.3.2 World Biosuperior Production by Region (2018-2029)
1.3.3 World Biosuperior Average Price by Region (2018-2029)
1.3.4 North America Biosuperior Production (2018-2029)
1.3.5 Europe Biosuperior Production (2018-2029)
1.3.6 China Biosuperior Production (2018-2029)
1.3.7 Japan Biosuperior Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosuperior Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biosuperior Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biosuperior Demand (2018-2029)
2.2 World Biosuperior Consumption by Region
2.2.1 World Biosuperior Consumption by Region (2018-2023)
2.2.2 World Biosuperior Consumption Forecast by Region (2024-2029)
2.3 United States Biosuperior Consumption (2018-2029)
2.4 China Biosuperior Consumption (2018-2029)
2.5 Europe Biosuperior Consumption (2018-2029)
2.6 Japan Biosuperior Consumption (2018-2029)
2.7 South Korea Biosuperior Consumption (2018-2029)
2.8 ASEAN Biosuperior Consumption (2018-2029)
2.9 India Biosuperior Consumption (2018-2029)
3 WORLD BIOSUPERIOR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biosuperior Production Value by Manufacturer (2018-2023)
3.2 World Biosuperior Production by Manufacturer (2018-2023)
3.3 World Biosuperior Average Price by Manufacturer (2018-2023)
3.4 Biosuperior Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biosuperior Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biosuperior in 2022
3.5.3 Global Concentration Ratios (CR8) for Biosuperior in 2022
3.6 Biosuperior Market: Overall Company Footprint Analysis
3.6.1 Biosuperior Market: Region Footprint
3.6.2 Biosuperior Market: Company Product Type Footprint
3.6.3 Biosuperior Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biosuperior Production Value Comparison
4.1.1 United States VS China: Biosuperior Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biosuperior Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biosuperior Production Comparison
4.2.1 United States VS China: Biosuperior Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biosuperior Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biosuperior Consumption Comparison
4.3.1 United States VS China: Biosuperior Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biosuperior Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biosuperior Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biosuperior Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biosuperior Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biosuperior Production (2018-2023)
4.5 China Based Biosuperior Manufacturers and Market Share
4.5.1 China Based Biosuperior Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biosuperior Production Value (2018-2023)
4.5.3 China Based Manufacturers Biosuperior Production (2018-2023)
4.6 Rest of World Based Biosuperior Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biosuperior Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biosuperior Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biosuperior Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosuperior Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 G-CSF Biobetters
5.2.2 Insulin Biobetters
5.2.3 Erythropoietin Biobetters
5.2.4 Monoclonal Antibodies Biobetters
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Biosuperior Production by Type (2018-2029)
5.3.2 World Biosuperior Production Value by Type (2018-2029)
5.3.3 World Biosuperior Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosuperior Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Diabetes
6.2.3 Genetic Disease
6.2.4 Neurological Disorders
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Biosuperior Production by Application (2018-2029)
6.3.2 World Biosuperior Production Value by Application (2018-2029)
6.3.3 World Biosuperior Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 F.Hoffmann-La Roche AG
7.1.1 F.Hoffmann-La Roche AG Details
7.1.2 F.Hoffmann-La Roche AG Major Business
7.1.3 F.Hoffmann-La Roche AG Biosuperior Product and Services
7.1.4 F.Hoffmann-La Roche AG Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 F.Hoffmann-La Roche AG Recent Developments/Updates
7.1.6 F.Hoffmann-La Roche AG Competitive Strengths & Weaknesses
7.2 Merck and Co.
7.2.1 Merck and Co. Details
7.2.2 Merck and Co. Major Business
7.2.3 Merck and Co. Biosuperior Product and Services
7.2.4 Merck and Co. Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck and Co. Recent Developments/Updates
7.2.6 Merck and Co. Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Biosuperior Product and Services
7.3.4 Sanofi Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 SERVIER
7.4.1 SERVIER Details
7.4.2 SERVIER Major Business
7.4.3 SERVIER Biosuperior Product and Services
7.4.4 SERVIER Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 SERVIER Recent Developments/Updates
7.4.6 SERVIER Competitive Strengths & Weaknesses
7.5 Porton Biopharma
7.5.1 Porton Biopharma Details
7.5.2 Porton Biopharma Major Business
7.5.3 Porton Biopharma Biosuperior Product and Services
7.5.4 Porton Biopharma Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Porton Biopharma Recent Developments/Updates
7.5.6 Porton Biopharma Competitive Strengths & Weaknesses
7.6 Eli Lily and Company
7.6.1 Eli Lily and Company Details
7.6.2 Eli Lily and Company Major Business
7.6.3 Eli Lily and Company Biosuperior Product and Services
7.6.4 Eli Lily and Company Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Eli Lily and Company Recent Developments/Updates
7.6.6 Eli Lily and Company Competitive Strengths & Weaknesses
7.7 Novo Nordisk
7.7.1 Novo Nordisk Details
7.7.2 Novo Nordisk Major Business
7.7.3 Novo Nordisk Biosuperior Product and Services
7.7.4 Novo Nordisk Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk Recent Developments/Updates
7.7.6 Novo Nordisk Competitive Strengths & Weaknesses
7.8 Biogen
7.8.1 Biogen Details
7.8.2 Biogen Major Business
7.8.3 Biogen Biosuperior Product and Services
7.8.4 Biogen Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biogen Recent Developments/Updates
7.8.6 Biogen Competitive Strengths & Weaknesses
7.9 CSL Behring GmbH
7.9.1 CSL Behring GmbH Details
7.9.2 CSL Behring GmbH Major Business
7.9.3 CSL Behring GmbH Biosuperior Product and Services
7.9.4 CSL Behring GmbH Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CSL Behring GmbH Recent Developments/Updates
7.9.6 CSL Behring GmbH Competitive Strengths & Weaknesses
7.10 Teva
7.10.1 Teva Details
7.10.2 Teva Major Business
7.10.3 Teva Biosuperior Product and Services
7.10.4 Teva Biosuperior Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Teva Recent Developments/Updates
7.10.6 Teva Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosuperior Industry Chain
8.2 Biosuperior Upstream Analysis
8.2.1 Biosuperior Core Raw Materials
8.2.2 Main Manufacturers of Biosuperior Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biosuperior Production Mode
8.6 Biosuperior Procurement Model
8.7 Biosuperior Industry Sales Model and Sales Channels
8.7.1 Biosuperior Sales Model
8.7.2 Biosuperior Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biosuperior Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biosuperior Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biosuperior Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biosuperior Production Value Market Share by Region (2018-2023)
Table 5. World Biosuperior Production Value Market Share by Region (2024-2029)
Table 6. World Biosuperior Production by Region (2018-2023) & (K Units)
Table 7. World Biosuperior Production by Region (2024-2029) & (K Units)
Table 8. World Biosuperior Production Market Share by Region (2018-2023)
Table 9. World Biosuperior Production Market Share by Region (2024-2029)
Table 10. World Biosuperior Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Biosuperior Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Biosuperior Major Market Trends
Table 13. World Biosuperior Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Biosuperior Consumption by Region (2018-2023) & (K Units)
Table 15. World Biosuperior Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Biosuperior Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biosuperior Producers in 2022
Table 18. World Biosuperior Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Biosuperior Producers in 2022
Table 20. World Biosuperior Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Biosuperior Company Evaluation Quadrant
Table 22. World Biosuperior Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biosuperior Production Site of Key Manufacturer
Table 24. Biosuperior Market: Company Product Type Footprint
Table 25. Biosuperior Market: Company Product Application Footprint
Table 26. Biosuperior Competitive Factors
Table 27. Biosuperior New Entrant and Capacity Expansion Plans
Table 28. Biosuperior Mergers & Acquisitions Activity
Table 29. United States VS China Biosuperior Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biosuperior Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Biosuperior Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Biosuperior Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biosuperior Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biosuperior Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biosuperior Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Biosuperior Production Market Share (2018-2023)
Table 37. China Based Biosuperior Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biosuperior Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biosuperior Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biosuperior Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Biosuperior Production Market Share (2018-2023)
Table 42. Rest of World Based Biosuperior Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biosuperior Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biosuperior Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biosuperior Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Biosuperior Production Market Share (2018-2023)
Table 47. World Biosuperior Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biosuperior Production by Type (2018-2023) & (K Units)
Table 49. World Biosuperior Production by Type (2024-2029) & (K Units)
Table 50. World Biosuperior Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biosuperior Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biosuperior Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Biosuperior Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Biosuperior Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biosuperior Production by Application (2018-2023) & (K Units)
Table 56. World Biosuperior Production by Application (2024-2029) & (K Units)
Table 57. World Biosuperior Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biosuperior Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biosuperior Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Biosuperior Average Price by Application (2024-2029) & (US$/Unit)
Table 61. F.Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 62. F.Hoffmann-La Roche AG Major Business
Table 63. F.Hoffmann-La Roche AG Biosuperior Product and Services
Table 64. F.Hoffmann-La Roche AG Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. F.Hoffmann-La Roche AG Recent Developments/Updates
Table 66. F.Hoffmann-La Roche AG Competitive Strengths & Weaknesses
Table 67. Merck and Co. Basic Information, Manufacturing Base and Competitors
Table 68. Merck and Co. Major Business
Table 69. Merck and Co. Biosuperior Product and Services
Table 70. Merck and Co. Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck and Co. Recent Developments/Updates
Table 72. Merck and Co. Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Biosuperior Product and Services
Table 76. Sanofi Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. SERVIER Basic Information, Manufacturing Base and Competitors
Table 80. SERVIER Major Business
Table 81. SERVIER Biosuperior Product and Services
Table 82. SERVIER Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. SERVIER Recent Developments/Updates
Table 84. SERVIER Competitive Strengths & Weaknesses
Table 85. Porton Biopharma Basic Information, Manufacturing Base and Competitors
Table 86. Porton Biopharma Major Business
Table 87. Porton Biopharma Biosuperior Product and Services
Table 88. Porton Biopharma Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Porton Biopharma Recent Developments/Updates
Table 90. Porton Biopharma Competitive Strengths & Weaknesses
Table 91. Eli Lily and Company Basic Information, Manufacturing Base and Competitors
Table 92. Eli Lily and Company Major Business
Table 93. Eli Lily and Company Biosuperior Product and Services
Table 94. Eli Lily and Company Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Eli Lily and Company Recent Developments/Updates
Table 96. Eli Lily and Company Competitive Strengths & Weaknesses
Table 97. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 98. Novo Nordisk Major Business
Table 99. Novo Nordisk Biosuperior Product and Services
Table 100. Novo Nordisk Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novo Nordisk Recent Developments/Updates
Table 102. Novo Nordisk Competitive Strengths & Weaknesses
Table 103. Biogen Basic Information, Manufacturing Base and Competitors
Table 104. Biogen Major Business
Table 105. Biogen Biosuperior Product and Services
Table 106. Biogen Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biogen Recent Developments/Updates
Table 108. Biogen Competitive Strengths & Weaknesses
Table 109. CSL Behring GmbH Basic Information, Manufacturing Base and Competitors
Table 110. CSL Behring GmbH Major Business
Table 111. CSL Behring GmbH Biosuperior Product and Services
Table 112. CSL Behring GmbH Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CSL Behring GmbH Recent Developments/Updates
Table 114. Teva Basic Information, Manufacturing Base and Competitors
Table 115. Teva Major Business
Table 116. Teva Biosuperior Product and Services
Table 117. Teva Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Biosuperior Upstream (Raw Materials)
Table 119. Biosuperior Typical Customers
Table 120. Biosuperior Typical Distributors
Table 1. World Biosuperior Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biosuperior Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biosuperior Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biosuperior Production Value Market Share by Region (2018-2023)
Table 5. World Biosuperior Production Value Market Share by Region (2024-2029)
Table 6. World Biosuperior Production by Region (2018-2023) & (K Units)
Table 7. World Biosuperior Production by Region (2024-2029) & (K Units)
Table 8. World Biosuperior Production Market Share by Region (2018-2023)
Table 9. World Biosuperior Production Market Share by Region (2024-2029)
Table 10. World Biosuperior Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Biosuperior Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Biosuperior Major Market Trends
Table 13. World Biosuperior Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Biosuperior Consumption by Region (2018-2023) & (K Units)
Table 15. World Biosuperior Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Biosuperior Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biosuperior Producers in 2022
Table 18. World Biosuperior Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Biosuperior Producers in 2022
Table 20. World Biosuperior Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Biosuperior Company Evaluation Quadrant
Table 22. World Biosuperior Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biosuperior Production Site of Key Manufacturer
Table 24. Biosuperior Market: Company Product Type Footprint
Table 25. Biosuperior Market: Company Product Application Footprint
Table 26. Biosuperior Competitive Factors
Table 27. Biosuperior New Entrant and Capacity Expansion Plans
Table 28. Biosuperior Mergers & Acquisitions Activity
Table 29. United States VS China Biosuperior Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biosuperior Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Biosuperior Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Biosuperior Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biosuperior Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biosuperior Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biosuperior Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Biosuperior Production Market Share (2018-2023)
Table 37. China Based Biosuperior Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biosuperior Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biosuperior Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biosuperior Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Biosuperior Production Market Share (2018-2023)
Table 42. Rest of World Based Biosuperior Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biosuperior Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biosuperior Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biosuperior Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Biosuperior Production Market Share (2018-2023)
Table 47. World Biosuperior Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biosuperior Production by Type (2018-2023) & (K Units)
Table 49. World Biosuperior Production by Type (2024-2029) & (K Units)
Table 50. World Biosuperior Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biosuperior Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biosuperior Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Biosuperior Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Biosuperior Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biosuperior Production by Application (2018-2023) & (K Units)
Table 56. World Biosuperior Production by Application (2024-2029) & (K Units)
Table 57. World Biosuperior Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biosuperior Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biosuperior Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Biosuperior Average Price by Application (2024-2029) & (US$/Unit)
Table 61. F.Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 62. F.Hoffmann-La Roche AG Major Business
Table 63. F.Hoffmann-La Roche AG Biosuperior Product and Services
Table 64. F.Hoffmann-La Roche AG Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. F.Hoffmann-La Roche AG Recent Developments/Updates
Table 66. F.Hoffmann-La Roche AG Competitive Strengths & Weaknesses
Table 67. Merck and Co. Basic Information, Manufacturing Base and Competitors
Table 68. Merck and Co. Major Business
Table 69. Merck and Co. Biosuperior Product and Services
Table 70. Merck and Co. Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck and Co. Recent Developments/Updates
Table 72. Merck and Co. Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Biosuperior Product and Services
Table 76. Sanofi Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. SERVIER Basic Information, Manufacturing Base and Competitors
Table 80. SERVIER Major Business
Table 81. SERVIER Biosuperior Product and Services
Table 82. SERVIER Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. SERVIER Recent Developments/Updates
Table 84. SERVIER Competitive Strengths & Weaknesses
Table 85. Porton Biopharma Basic Information, Manufacturing Base and Competitors
Table 86. Porton Biopharma Major Business
Table 87. Porton Biopharma Biosuperior Product and Services
Table 88. Porton Biopharma Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Porton Biopharma Recent Developments/Updates
Table 90. Porton Biopharma Competitive Strengths & Weaknesses
Table 91. Eli Lily and Company Basic Information, Manufacturing Base and Competitors
Table 92. Eli Lily and Company Major Business
Table 93. Eli Lily and Company Biosuperior Product and Services
Table 94. Eli Lily and Company Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Eli Lily and Company Recent Developments/Updates
Table 96. Eli Lily and Company Competitive Strengths & Weaknesses
Table 97. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 98. Novo Nordisk Major Business
Table 99. Novo Nordisk Biosuperior Product and Services
Table 100. Novo Nordisk Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novo Nordisk Recent Developments/Updates
Table 102. Novo Nordisk Competitive Strengths & Weaknesses
Table 103. Biogen Basic Information, Manufacturing Base and Competitors
Table 104. Biogen Major Business
Table 105. Biogen Biosuperior Product and Services
Table 106. Biogen Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biogen Recent Developments/Updates
Table 108. Biogen Competitive Strengths & Weaknesses
Table 109. CSL Behring GmbH Basic Information, Manufacturing Base and Competitors
Table 110. CSL Behring GmbH Major Business
Table 111. CSL Behring GmbH Biosuperior Product and Services
Table 112. CSL Behring GmbH Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CSL Behring GmbH Recent Developments/Updates
Table 114. Teva Basic Information, Manufacturing Base and Competitors
Table 115. Teva Major Business
Table 116. Teva Biosuperior Product and Services
Table 117. Teva Biosuperior Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Biosuperior Upstream (Raw Materials)
Table 119. Biosuperior Typical Customers
Table 120. Biosuperior Typical Distributors
LIST OF FIGURES
Figure 1. Biosuperior Picture
Figure 2. World Biosuperior Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biosuperior Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biosuperior Production (2018-2029) & (K Units)
Figure 5. World Biosuperior Average Price (2018-2029) & (US$/Unit)
Figure 6. World Biosuperior Production Value Market Share by Region (2018-2029)
Figure 7. World Biosuperior Production Market Share by Region (2018-2029)
Figure 8. North America Biosuperior Production (2018-2029) & (K Units)
Figure 9. Europe Biosuperior Production (2018-2029) & (K Units)
Figure 10. China Biosuperior Production (2018-2029) & (K Units)
Figure 11. Japan Biosuperior Production (2018-2029) & (K Units)
Figure 12. Biosuperior Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biosuperior Consumption (2018-2029) & (K Units)
Figure 15. World Biosuperior Consumption Market Share by Region (2018-2029)
Figure 16. United States Biosuperior Consumption (2018-2029) & (K Units)
Figure 17. China Biosuperior Consumption (2018-2029) & (K Units)
Figure 18. Europe Biosuperior Consumption (2018-2029) & (K Units)
Figure 19. Japan Biosuperior Consumption (2018-2029) & (K Units)
Figure 20. South Korea Biosuperior Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Biosuperior Consumption (2018-2029) & (K Units)
Figure 22. India Biosuperior Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Biosuperior by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biosuperior Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biosuperior Markets in 2022
Figure 26. United States VS China: Biosuperior Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biosuperior Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biosuperior Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biosuperior Production Market Share 2022
Figure 30. China Based Manufacturers Biosuperior Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biosuperior Production Market Share 2022
Figure 32. World Biosuperior Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biosuperior Production Value Market Share by Type in 2022
Figure 34. G-CSF Biobetters
Figure 35. Insulin Biobetters
Figure 36. Erythropoietin Biobetters
Figure 37. Monoclonal Antibodies Biobetters
Figure 38. Others
Figure 39. World Biosuperior Production Market Share by Type (2018-2029)
Figure 40. World Biosuperior Production Value Market Share by Type (2018-2029)
Figure 41. World Biosuperior Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Biosuperior Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Biosuperior Production Value Market Share by Application in 2022
Figure 44. Cancer
Figure 45. Diabetes
Figure 46. Genetic Disease
Figure 47. Neurological Disorders
Figure 48. Others
Figure 49. World Biosuperior Production Market Share by Application (2018-2029)
Figure 50. World Biosuperior Production Value Market Share by Application (2018-2029)
Figure 51. World Biosuperior Average Price by Application (2018-2029) & (US$/Unit)
Figure 52. Biosuperior Industry Chain
Figure 53. Biosuperior Procurement Model
Figure 54. Biosuperior Sales Model
Figure 55. Biosuperior Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Biosuperior Picture
Figure 2. World Biosuperior Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biosuperior Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biosuperior Production (2018-2029) & (K Units)
Figure 5. World Biosuperior Average Price (2018-2029) & (US$/Unit)
Figure 6. World Biosuperior Production Value Market Share by Region (2018-2029)
Figure 7. World Biosuperior Production Market Share by Region (2018-2029)
Figure 8. North America Biosuperior Production (2018-2029) & (K Units)
Figure 9. Europe Biosuperior Production (2018-2029) & (K Units)
Figure 10. China Biosuperior Production (2018-2029) & (K Units)
Figure 11. Japan Biosuperior Production (2018-2029) & (K Units)
Figure 12. Biosuperior Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biosuperior Consumption (2018-2029) & (K Units)
Figure 15. World Biosuperior Consumption Market Share by Region (2018-2029)
Figure 16. United States Biosuperior Consumption (2018-2029) & (K Units)
Figure 17. China Biosuperior Consumption (2018-2029) & (K Units)
Figure 18. Europe Biosuperior Consumption (2018-2029) & (K Units)
Figure 19. Japan Biosuperior Consumption (2018-2029) & (K Units)
Figure 20. South Korea Biosuperior Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Biosuperior Consumption (2018-2029) & (K Units)
Figure 22. India Biosuperior Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Biosuperior by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biosuperior Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biosuperior Markets in 2022
Figure 26. United States VS China: Biosuperior Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biosuperior Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biosuperior Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biosuperior Production Market Share 2022
Figure 30. China Based Manufacturers Biosuperior Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biosuperior Production Market Share 2022
Figure 32. World Biosuperior Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biosuperior Production Value Market Share by Type in 2022
Figure 34. G-CSF Biobetters
Figure 35. Insulin Biobetters
Figure 36. Erythropoietin Biobetters
Figure 37. Monoclonal Antibodies Biobetters
Figure 38. Others
Figure 39. World Biosuperior Production Market Share by Type (2018-2029)
Figure 40. World Biosuperior Production Value Market Share by Type (2018-2029)
Figure 41. World Biosuperior Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Biosuperior Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Biosuperior Production Value Market Share by Application in 2022
Figure 44. Cancer
Figure 45. Diabetes
Figure 46. Genetic Disease
Figure 47. Neurological Disorders
Figure 48. Others
Figure 49. World Biosuperior Production Market Share by Application (2018-2029)
Figure 50. World Biosuperior Production Value Market Share by Application (2018-2029)
Figure 51. World Biosuperior Average Price by Application (2018-2029) & (US$/Unit)
Figure 52. Biosuperior Industry Chain
Figure 53. Biosuperior Procurement Model
Figure 54. Biosuperior Sales Model
Figure 55. Biosuperior Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
